Stigma in gestational diabetes 30 March 2026 Our research impact Challenge Diabetes stigma can harm emotional and social wellbeing, self-care, and access to healthcare. While stigma in other types of diabetes has been studied, little was known about stigma in gestational diabetes (GDM). There has also been no tool to measure GDM-related stigma, limiting efforts to address it. Bold idea With support from Diabetes Australia, this study explored how Australian women with GDM experience stigma and co-developed the first comprehensive questionnaire to measure it. This project was led by Dr Elizabeth Holmes-Truscott who has lived experience of GDM and is Deputy Director of the Australian Centre for Behavioural Research in Diabetes (a partnership between Diabetes Victoria and Deakin University). Impact The study gave new insights into women’s experiences of GDM-related stigma. Women described stigma driven by stereotypes and blame, shaped by social expectations about pregnancy and motherhood, media messages, and inconsistent healthcare. They reported emotional and social impacts of stigma, challenges with self-care, and reduced autonomy in healthcare decisions. Women also identified protective factors. These included supportive healthcare and social networks, self-belief, and greater community awareness of GDM. Findings informed the co-design of questions to measure GDM-related stigma, now ready for further testing. This tool will support future research to measure prevalence, understand impacts, and evaluate stigma-reduction efforts. This work also supports Elizabeth’s co-leadership of the Global Pledge to End Diabetes Stigma. Learn more about diabetes research and our research impact.
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading
News 20 July 2026 Response to media reports from 60 Minutes, The Sydney Morning Herald, and The Age regarding regulation of diabetes technologies The safety of people living with diabetes must always come first. For many Australians, technologies such as insulin pumps and continuous glucose monitors are essential tools that help prevent dangerous high and low blood glucose levels, reduce the daily burden of living with diabetes and improve long-term health outcomes. For some individuals they can be life-changing or even life-saving. Continue Reading
Media releases 8 July 2026 Territory-led digital health innovation receives boost from national partnership A major funding boost will expand digital health solutions for complex care in the Northern Territory (NT), thanks to a joint investment from Diabetes Australia and Lilly Australia, in partnership with Menzies School of Health Research (Menzies). Continue Reading